Dedicated, prospective studies with adequate sample sizes, long-term follow-up, and comprehensive metabolic phenotyping are urgently required to validate these preliminary observations and establish evidence-based, genotype-specific treatment approaches
Finding the optimal dose for your needs can take some trial-and-error - for example, you may choose to maintain a lower dose if you experience more gastrointestinal symptoms on 7.2 mg
By reducing menopause symptoms such as fatigue, night sweats, and mood swings, women often feel more motivated and capable of engaging in regular physical activity
the specific return process steps
The Eating Disorder Risk Signal: What Every Prescriber Needs to Know As of 2026, GLP-1 medications carry no eating disorder warning on their FDA-approved labeling
GLP-1 does several important things